SHUKRA PHARMACEUTICALS LIMITED

Scale -

Revenue is 56.73 Rs Cr; Annual Growth is 74 %; 5 Year CAGR is 74 %
Ebitda is 33.32 Rs Cr; Annual Growth is 97 %; in Top Quartile; 5 Year CAGR is 97 %
PBT is 18.17 Rs Cr; Annual Growth is 116 %; in Top Quartile; 5 Year CAGR is 116 %
PAT is 22.06 Rs Cr; Annual Growth is 130 %; in Top Quartile; 5 Year CAGR is 130 %
Quarterly Ebitda is 19.14 Rs Cr; in Top Quartile

Profitability -

PBDIT Margin is 58.74 %; Annual Growth is 13 %; in Top Quartile; 5 Year CAGR is 13 %
PAT Margin is 38.88 %; Annual Growth is 32 %; in Top Quartile; 5 Year CAGR is 32 %
Quarterly Ebitda Margin is 81 %; in Top Quartile
Quarterly Profit margin is 55 %; in Top Quartile

Return -

ROCE is 31.67 %; Annual Growth is 58 %; in Top Quartile; 5 Year CAGR is 58 %
ROA is 18.78 %; Annual Growth is 70 %; in Top Quartile; 5 Year CAGR is 70 %
ROE is 24.55 %; Annual Growth is 61 %; in Top Quartile; 5 Year CAGR is 61 %

Asset Turnover is 0 %; in Bottom Quartile

Efficiency -

Current Ratio is 3.63; in Top Quartile
Quick Ratio is 3.03; in Top Quartile

Operating cash flow is 3.93 Rs Cr; Annual Decline is -50 %; 5 Year CAGR is -50 %
Inventory Turnover Ratio is 0; in Bottom Quartile

Solvancy -

Total Debt is 5.02 Rs Cr; 5 Year CAGR is 20 %

Quality -

Current Tax/PAT is 31 %; Annual Decline is -22 %; 5 Year CAGR is -22 %
Other Expenses/Total Expenses is 16 %; Annual Decline is -35 %; 5 Year CAGR is -35 %
Change in Inventories/Total Expenses is -11 %; in Bottom Quartile

Operating cashflow/ebitda is 12 %; Annual Decline is -75 %; 5 Year CAGR is -75 %
Operating cashflow/PAT is 18 %; Annual Decline is -78 %; 5 Year CAGR is -78 %
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: